Compare Aehr Test Systems (AEHR) vs Docusign Inc (DOCU) Price & Performance

AEHR trades at $72.33, up 3.38% today, with a bullish technical signal driven by oversold RSI readings near 24.5, though moving averages remain bearish. The company reported Q1 2026 EPS of -$0.05, beating expectations, but maintains negative profitability margins and cash flow. Recent news highlights strong order growth from AI and silicon photonics customers, including a follow-on system order announced June 17, 2026.

Outlook is mixed: robust order book and AI sector tailwinds support growth, but high P/S of 46.6 and persistent losses pose valuation risks. Analyst consensus is cautious with 33% buy ratings. Key risks include execution on orders and cash burn.

DOCU trades at $47.23, up 3.19% with a bullish technical signal. Recent earnings consistently beat expectations, with Q1 2026 EPS of $1.09 exceeding estimates. Revenue growth remains steady, reaching $2.98B in 2025, while profitability improved significantly with a net income margin of 35.87%. The company's partnerships with Perplexity and Slack highlight ongoing innovation in agreement management workflows, supporting future growth prospects amid positive analyst sentiment.

The outlook for DOCU is cautiously optimistic, with a consensus price target of $55.40 suggesting 17% upside. Key opportunities include expanding AI integration and enterprise adoption, but risks involve competitive pressures and reliance on subscription revenue stability. Valuation metrics like a P/E of 30.45 require sustained earnings growth to justify current levels, making execution critical for shareholder returns.